HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical and laboratory evaluation of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370) in rheumatoid arthritis and ankylosing spondylitis.

AuthorsG C Lignière, B Colombo, M Carrabba, P Ferrari, E Robotti
JournalArzneimittel-Forschung (Arzneimittelforschung) Vol. 22 Issue 1 Pg. Suppl 1a:253-8 (Jan 1972) ISSN: 0004-4172 [Print] Germany
PMID4553232 (Publication Type: Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Anti-Inflammatory Agents
  • Placebos
  • Pyrazoles
  • Terpenes
  • Phenylbutazone
Topics
  • Adult
  • Aged
  • Anti-Inflammatory Agents (adverse effects, metabolism, therapeutic use)
  • Arthritis, Rheumatoid (drug therapy)
  • Clinical Trials as Topic
  • Female
  • Half-Life
  • Humans
  • Male
  • Middle Aged
  • Phenylbutazone (adverse effects, metabolism, therapeutic use)
  • Placebos
  • Pyrazoles (adverse effects, metabolism, therapeutic use)
  • Spondylitis, Ankylosing (drug therapy)
  • Terpenes (adverse effects, metabolism, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: